Park Ha Biological Technology Co. Ltd. (PHH) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Park Ha Biological Technology Co. Ltd. (PHH:NASDAQ), powered by AI.

Current Price
$0.18
Sector
Consumer Defensive
What is the Park Ha Biological Technology Co. Ltd. stock price forecast?

Park Ha Biological Technology Co. Ltd. is currently trading at $0.18. View real-time AI analysis on Alpha Lenz.

What is Park Ha Biological Technology Co. Ltd. insider trading activity?

View the latest insider trading data for Park Ha Biological Technology Co. Ltd. on Alpha Lenz.

What is Park Ha Biological Technology Co. Ltd.'s P/E ratio?

View Park Ha Biological Technology Co. Ltd.'s valuation metrics on Alpha Lenz.

Park Ha Biological Technology Co. Ltd.

NASDAQ · PHH
$0.18-0.01(-2.95%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Park Ha Biological Technology Co. Ltd.'s future dividend policy...

Company Overview

Park Ha Biological Technology Co. Ltd. is a dynamic player in the biotechnology industry, focusing on the development and commercialization of innovative biological solutions. With a commitment to advancing healthcare, the company engages in extensive research and development of therapeutic products. These products often address unmet medical needs, leveraging cutting-edge biotechnological methodologies. Park Ha Biological Technology Co. Ltd. operates within a broad spectrum of sectors, including pharmaceuticals, agribiotechnology, and environmental biotechnology, thereby impacting both human health and sustainable development. The company's contributions to the biotech sector are accentuated by its robust pipeline of products at various stages of development and its strategic partnerships with other industry leaders. As a crucial participant in the biotech market, Park Ha Biological Technology Co. Ltd. plays a significant role in driving technological advancements and has a notable presence in global health initiatives.

CEOMs. Xiaoqiu Zhang
SectorConsumer Defensive
IndustryHousehold & Personal Products
Employees17

Company Statistics

Profile

N/AMarket Cap
N/ARevenue
0.00Shares Out
17Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

N/AROA
N/AROE
N/AROIC

Financial Health

N/ACash & Cash Equivalents
N/ANet Debt
N/ADebt/Equity
N/AInterest Cov

Frequently Asked Questions

Park Ha Biological Technology Co. Ltd. (ticker: PHH) is a company listed on NASDAQ in the Consumer Defensive sector (Household & Personal Products). It has approximately 17 employees.

The current price is $0.178 with a P/E ratio of -x and P/B of -x.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Park Ha Biological Technology Co. Ltd. (PHH) Stock Forecast 2026 $0.18 — Price, Financials & Analyst Targets | Alpha Lenz